Clinical Trial Update: A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating different doses of BI 685509 for kidney function in diabetic kidney disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• BI 685509

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetic Nephropathies | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23